Toxicology Reagent CEDIA® Benzodiazepine (BZO) CLIA Non-Waived For Clinical Chemistry Analyzers

Name: Toxicology Reagent
Brand: CEDIA®

REAGENT, IMMUNOASSAY CEDIA BENZODIAZEPINE INDIKO 3X17ML D/S

McKesson #

1254849

Manufacturer #

10016409

Brand

CEDIA®

Manufacturer

Microgenics

Country of Origin

Unknown

Application

Toxicology Reagent

CLIA Classification

CLIA Non-Waived

CLIA Classified

CLIA Non-Waived

Container Type

Bottle

For Use With

For Clinical Chemistry Analyzers

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Sample Type

Urine Sample

Specialty

Toxicology

Storage Requirements

Requires Refrigeration

Test Category

Drugs of Abuse

Test Method

Homogeneous Enzyme Immunoassay (HEIA)

Test Name

Benzodiazepine (BZO)

Test Type

Single Drug

UNSPSC Code

41116007

Volume

3 X 17 mL

The CEDIA Benzodiazepine Assay is a homogeneous enzyme immunoassay intended for the qualitative and/or semi-quantitative determination of benzodiazepines in human urine at a cutoff concentration of 200 ng/mL
Chemistry analyzers which are capable of maintaining a constant temperature, pipetting samples, mixing reagents, measuring enzymatic rates and timing the reaction accurately can be used to perform this assay
Qualitative or semi-quantitative options for results